ID | Name | Number of studies | |
|---|---|---|---|
| CL_0000624 | CD4-positive, alpha-beta T cell | 48 | |
| CL_0000934 | CD4-positive, alpha-beta cytotoxic T cell | 8 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
|---|---|---|---|---|---|
| CXCR6 | 3 | 25% ± 4% | 0 | 9 | |
| PRF1 | 4 | 32% ± 14% | 0 | 21 | |
| IFNG | 3 | 19% ± 3% | 0 | 11 | |
| LAG3 | 3 | 28% ± 11% | 0 | 12 | |
| CD5 | 3 | 28% ± 7% | 0 | 20 | |
| CD6 | 3 | 37% ± 11% | 0 | 24 | |
| ZAP70 | 3 | 34% ± 12% | 0 | 27 | |
| GZMM | 3 | 43% ± 8% | 0 | 27 | |
| GZMA | 6 | 58% ± 25% | 1 | 26 | |
| GNLY | 4 | 41% ± 10% | 1 | 20 | |
| SLAMF1 | 3 | 28% ± 10% | 1 | 10 | |
| KLRB1 | 4 | 37% ± 16% | 1 | 26 | |
| CD3G | 4 | 51% ± 17% | 1 | 29 | |
| CD3D | 5 | 60% ± 31% | 2 | 34 | |
| TNFRSF18 | 3 | 40% ± 13% | 2 | 15 | |
| CD2 | 5 | 61% ± 28% | 2 | 35 | |
| TNFRSF4 | 3 | 48% ± 8% | 2 | 15 | |
| BATF | 3 | 43% ± 8% | 2 | 23 | |
| LCK | 4 | 54% ± 28% | 2 | 34 | |
| CD247 | 4 | 39% ± 20% | 2 | 34 | |
| CD96 | 3 | 31% ± 9% | 2 | 33 | |
| SELPLG | 3 | 36% ± 23% | 2 | 34 | |
| CD3E | 5 | 72% ± 29% | 3 | 37 | |
| SKAP1 | 4 | 34% ± 11% | 3 | 35 | |
| GIMAP7 | 4 | 33% ± 17% | 3 | 41 | |
| ITGAL | 3 | 35% ± 7% | 3 | 36 | |
| CST7 | 5 | 67% ± 26% | 4 | 36 | |
| NKG7 | 5 | 62% ± 28% | 4 | 40 | |
| CCL5 | 4 | 57% ± 22% | 4 | 33 | |
| CD69 | 6 | 47% ± 6% | 4 | 54 |
| GO_0045190 | Biological process | isotype switching |
| GO_0002841 | Biological process | negative regulation of T cell mediated immune response to tumor cell |
| GO_0002903 | Biological process | negative regulation of B cell apoptotic process |
| Cell type name | CD4-positive, alpha-beta cytotoxic T cell |
| Synonyms | CD4-positive alpha-beta cytotoxic T lymphocyte CD4-positive alpha-beta cytotoxic T-cell CD4-positive alpha-beta cytotoxic T-lymphocyte |
| Description | A CD4-positive, alpha-beta T cell that has cytotoxic function. |
| Parent | CL_0000624 |